A detailed history of O'Shaughnessy Asset Management, LLC transactions in Genmab A/S stock. As of the latest transaction made, O'Shaughnessy Asset Management, LLC holds 17,503 shares of GMAB stock, worth $360,386. This represents 0.0% of its overall portfolio holdings.

Number of Shares
17,503
Holding current value
$360,386
% of portfolio
0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$23.84 - $28.48 $417,271 - $498,485
17,503 New
17,503 $426,000
Q1 2024

May 13, 2024

BUY
$26.43 - $32.77 $224,945 - $278,905
8,511 New
8,511 $254,000
Q3 2023

Nov 13, 2023

BUY
$35.27 - $42.24 $205,483 - $246,090
5,826 New
5,826 $205,000
Q4 2022

Feb 10, 2023

BUY
$33.8 - $47.06 $169,946 - $236,617
5,028 New
5,028 $213,000
Q4 2021

Feb 11, 2022

SELL
$35.87 - $47.12 $96,562 - $126,847
-2,692 Closed
0 $0
Q3 2021

Nov 10, 2021

BUY
$41.55 - $48.72 $2,077 - $2,436
50 Added 1.89%
2,692 $118,000
Q2 2021

Aug 09, 2021

BUY
$32.88 - $44.57 $5,359 - $7,264
163 Added 6.58%
2,642 $108,000
Q1 2021

May 14, 2021

BUY
$30.92 - $44.4 $4,792 - $6,882
155 Added 6.67%
2,479 $81,000
Q4 2020

Feb 11, 2021

BUY
$33.66 - $40.76 $2,995 - $3,627
89 Added 3.98%
2,324 $94,000
Q3 2020

Nov 12, 2020

BUY
$33.07 - $38.68 $13,558 - $15,858
410 Added 22.47%
2,235 $82,000
Q2 2020

Aug 13, 2020

BUY
$20.05 - $33.89 $25,283 - $42,735
1,261 Added 223.58%
1,825 $62,000
Q1 2020

May 13, 2020

SELL
$17.15 - $25.22 $4,922 - $7,238
-287 Reduced 33.73%
564 $12,000
Q4 2019

Feb 12, 2020

BUY
$18.88 - $24.14 $16,066 - $20,543
851 New
851 $19,000

Others Institutions Holding GMAB

About GENMAB A/S


  • Ticker GMAB
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 658,292,992
  • Market Cap $13.6B
  • Description
  • Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...
More about GMAB
Track This Portfolio

Track O'Shaughnessy Asset Management, LLC Portfolio

Follow O'Shaughnessy Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of O'Shaughnessy Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on O'Shaughnessy Asset Management, LLC with notifications on news.